ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study Paris, April 18, 2026. Sanofi's protein-based non-mRNA COVID-19 vaccine Nuvaxovid (NVX-CoV2705) demonstrated statistically significant lower systemic reactogenicity (the expected side effects that might occur following vaccination) compared to mNEXSPIKE (mRNA-1283), Moderna's latest mRNA COVID-19 vaccine, across all pre-specified endpoints in the COMPARE…
MONACO, April 18, 2026 (GLOBE NEWSWIRE) -- AlphaPepe has crossed $880,000 in presale capital raised and stages continue finalizing in days. Capital is entering at a pace that most projects in 2026 have failed to generate. The crypto news around AlphaPepe is building ahead of a planned Q2 2026 exchange listing while the Ethereum price…
Pinellas Park, FL, April 17, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to the buyer. This article is an informational overview and does not constitute medical, health, or dietary advice. All product details described below are…
FORT WORTH, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today issued the following statement: We appreciate the leadership and strong support of President Trump, Secretary Duffy and numerous other leaders in the Administration who have demonstrated expertise and an ongoing commitment to continue to improve the world’s best aviation…
OAK RIDGE, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Today, Kairos Power broke ground on the Hermes 2 Demonstration Plant in Oak Ridge, Tenn. – the company’s first commercial-scale reactor and the first-ever power-producing Gen IV reactor to receive a construction permit from the Nuclear Regulatory Commission (NRC). (Photos and video)
